Articles

Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT

Department of Stem Cell Transplantation, University Medical Center Hamburg- Eppendorf, Hamburg, Germany
EBMT Data Office, Leiden, the Netherlands
Dipartimento di Biologia, Università degli Study di Roma “Tor Vergata”, Italy
EBMT Data Office, Leiden, the Netherlands
Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
Institut Paoli Calmettes, Marseille, France
St. István and St. László Hospital, Budapest, Hungary
Hématologie Clinique, Dijon University Hospital, Dijon, France
Department of Hematology, Skane University Hospital Lund, Sweden
Department of Hematology, Bone Marrow Transplant Unit, Debrecen Medical University, Hungary
Department of Haematology, Cambridge University Hospitals, UK
University Tor Vergata, Roma, Italy
Department of Hematology, Grenoble University Hospital, France
Leicester Royal Infirmary, Leicester
Hematology, Hôpital La Mileterie, Poitiers, France
Haga Teaching Hospital, the Hague, the Netherlands
Department of Hematology, UZ Leuven, Belgium
Hematology, Ospedale San Gerardo ASST Monza- Università degli Studi di Milano Bicocca, Monza, Italy
Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Turku University Hospital, Finland
Division of Hematology, Casa di Cura “La Maddalena”, Palermo, Italy
EBMT Data Office, Leiden, the Netherlands
Hopital St Antoine, Paris, France
Department of Stem Cell Transplantation, University Medical Center Hamburg- Eppendorf, Hamburg, Germany
Vol. 103 No. 5 (2018): May, 2018 https://doi.org/10.3324/haematol.2017.178434